Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : PARANOID! TIRED OF TALKING TO YOURSELF? LET'S TALK(TTP) -- Ignore unavailable to you. Want to Upgrade?

To: Pseudo Biologist who wrote (11)	3/4/1998 7:10:00 AM
From: Arthur Radley	Respond to of 626

Thanks PB for posting the financials on TTNP. As you can see, their bank account isn't overflowing, but with Novartis backing the Phase III trials for ILOPERIDONE, this frees their money to support the other projects. If the PHASE III trials are a success, with the NDA approval the flow of royalty from NOVARTIS will have an immediate impact on their financial footing. As stated, this is a $5.00 stock currently and I would think that is based on their current status, but the future looks very promising (IMO). Logic would be that they will sign up with another major drug company with their cancer indications and SPERAMINE, if the Phase I study goes well.